Dr. Deepak Balaji Thimiri Govindaraj is a Centre Manager of CSIR Synthetic Biology Centre. Deepak Balaji is a chemical engineer by training and has worked on nanobiotechnology, industrial synthetic biology and drug screening for precision medicine. During his PhD in KU Leuven Belgium, Deepak worked on Nanobiotechnology methods for cell surface proteomics. The work resulted in 2 International Patent. Deepak then went to EMBL for a Marie Curie Fellow where he designed synthetic baculovirus genome for recombinant protein expression. The work is internationally patented and sold in the market as a product by Geneva Biotech, Switzerland. As a Senior Scientist at Oslo University hospital Norway, Deepak established the drug sensitivity screening platform for blood cancer. As a Centre Manager at CSIR Pretoria, Deepak is currently establishing Synthetic Biology and Precision Medicine programs.
